# EDGAR Filing Document

**Accession Number:** 0000018498
**File Stem:** 0001193125-25-315336
**Filing Date:** 2025-12
**Character Count:** 115631
**Document Hash:** 6fe66d2c4bba4eb9498fe236c4899581
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-315336.hdr.sgml**: 20251211

**ACCESSION NUMBER**: 0001193125-25-315336

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 48

**CONFORMED PERIOD OF REPORT**: 20251101

**FILED AS OF DATE**: 20251211

**DATE AS OF CHANGE**: 20251211

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GENESCO INC
- **CENTRAL INDEX KEY:** 0000018498
- **STANDARD INDUSTRIAL CLASSIFICATION:** RETAIL-SHOE STORES [5661]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 620211340
- **STATE OF INCORPORATION:** TN
- **FISCAL YEAR END:** 0201

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-03083
- **FILM NUMBER:** 251563834

**BUSINESS ADDRESS:**
- **STREET 1:** 535 MARRIOTT DRIVE
- **STREET 2:** 12TH FLOOR
- **CITY:** NASHVILLE
- **STATE:** TN
- **ZIP:** 37214
- **BUSINESS PHONE:** 6153677000

**MAIL ADDRESS:**
- **STREET 1:** 535 MARRIOTT DRIVE
- **STREET 2:** 12TH FLOOR
- **CITY:** NASHVILLE
- **STATE:** TN
- **ZIP:** 37214

?xml version='1.0' encoding='ASCII'? 10-Q

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM** 10-Q

(Mark One)

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarter Ended** **November 1,** 2025

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to** 

**Commission File No.** 1-3083

Genesco Inc**.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| Tennessee | Tennessee | 62-0211340 |
| (State or other jurisdiction of<br>incorporation or organization) | (State or other jurisdiction of<br>incorporation or organization) | (I.R.S. Employer<br>Identification No.) |
|  | 535 Marriott Drive | 37214 |
| Nashville**,** | Tennessee | (Zip Code) |
| (Address of principal executive offices) | (Address of principal executive offices) |  |

---

**Registrant's telephone number, including area code: (**615**)** 367-7000

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, $1.00 par value | GCO | New York Stock Exchange |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such report), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer; an accelerated filer; a non-accelerated filer; a smaller reporting company; or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act:

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☒ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| Emerging growth company | ☐ |  |  |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No ☒

As of November 28, 2025, there were 10,792,736 shares of the registrant's common stock outstanding.

------

**INDEX**

---

| | |
|:---|:---|
| [**<u>Part I. Financial Information</u>**](#part_i_financial_information) |  |
| [<u>Item 1. Financial Statements:</u>](#item_1_financial_statements_unaudited) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Condensed Consolidated Balance Sheets - November 1, 2025, February 1, 2025 and November 2, 2024</u>](#condensed_consolidated_balance_sheets) | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Condensed Consolidated Statements of Operations - Three and Nine Months ended November 1, 2025 and November 2, 2024</u>](#condensed_consolidated_statements_operat) | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Condensed Consolidated Statements of Comprehensive Income (Loss) - Three and Nine Months ended November 1, 2025 and November 2, 2024</u>](#condensed_consolidated_statements_compre) | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Condensed Consolidated Statements of Cash Flows - Nine Months ended November 1, 2025 and November 2, 2024</u>](#condensed_consolidated_statements_cash_f) | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Condensed Consolidated Statements of Equity - Three and Nine Months ended November 1, 2025 and November 2, 2024</u>](#condensed_consolidated_statements_equity) | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Notes to Condensed Consolidated Financial Statements</u>](#notes_to_financial_statements) | 9 |
| [<u>Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations</u>](#item_2_mda) | 17 |
| [<u>Item 3. Quantitative and Qualitative Disclosures about Market Risk</u>](#item_3_quantitative_qualitative_disclosu) | 25 |
| [<u>Item 4. Controls and Procedures</u>](#item_4_controls_procedures) | 25 |
| [**<u>Part II. Other Information</u>**](#part_ii_or_information) | 26 |
| [<u>Item 1. Legal Proceedings</u>](#item_1_legal_proceedings) | 26 |
| [<u>Item 1A. Risk Factors</u>](#item_1a_risk_factors) | 26 |
| [<u>Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</u>](#item_2_unregistered_sales) | 27 |
| [<u>Item 5. Other Information</u>](#item_5_other_information) | 27 |
| [<u>Item 6. Exhibits</u>](#item_6_exhibits) | 28 |
| [<u>Signature</u>](#signature) | 29 |

---

------

**cautionary notice regarding forward-looking statements** 

Statements in this Quarterly Report on Form 10-Q include certain forward-looking statements, which include statements regarding our intent, belief or expectations and all statements other than those made solely with respect to historical fact. Actual results could differ materially from those reflected by the forward-looking statements in this Quarterly Report on Form 10-Q and a number of factors may adversely affect the forward-looking statements and our future results, liquidity, capital resources or prospects. These include, but are not limited to, adjustments to projections reflected in forward-looking statements, including those resulting from weakness in store, e-commerce and shopping mall traffic, the imposition of tariffs (including the timing and amount thereof) on products imported by us or our vendors as well as the ability and costs to move production of products in response to tariffs, restrictions on operations imposed by government entities and/or landlords, changes in public safety and health requirements and limitations on our ability to adequately staff and operate stores. Differences from expectations could also result from store closures and effects on the business as a result of the level of consumer spending on our merchandise and interest in our brands and in general; the level and timing of promotional activity necessary to maintain inventories at appropriate levels; our ability to pass on price increases to our customers; the timing and amount of any share repurchases by us; our ability to obtain from suppliers products that are in demand on a timely basis and effectively manage disruptions in product supply or distribution, including disruptions as a result of pandemics or geopolitical events, including shipping disruptions near crucial trade routes; unfavorable trends in fuel costs, foreign exchange rates, foreign labor and material costs; a disruption in shipping or increase in cost of our imported products, and other factors affecting the cost of products; our dependence on third-party vendors and licensors for the products we sell; our ability to renew our license agreements; impacts of the Russia-Ukraine war, the conflict in Israel and the surrounding areas; market weakness in the locations in which we operate; the effectiveness of our omni-channel initiatives; costs associated with changes in minimum wage and overtime requirements; wage pressures; labor shortages; the effects of inflation; the evolving regulatory landscape related to our use of social media; the establishment and protection of our intellectual property; weakness in the consumer economy and retail industry; competition and fashion trends in our markets, including trends with respect to the popularity of casual and dress footwear; any failure to increase sales at our existing stores, given our high fixed expense cost structure, and in our e-commerce businesses; risks related to the potential for terrorist events; store closures and effects on the business as a result of civil disturbances; risks related to public health and safety events; changes in buying patterns by significant wholesale customers; changes in consumer preferences; our ability to continue to complete and integrate acquisitions; our ability to expand our business and diversify our product base; impairment of goodwill in connection with acquisitions; payment related risks that could increase our operating cost, expose us to fraud or theft, subject us to potential liability and disrupt our business; retained liabilities associated with divestitures of businesses including potential liabilities under leases as the prior tenant or as a guarantor of certain leases; and changes in the timing of holidays or in the onset of seasonal weather affecting period-to-period sales comparisons. Additional factors that could cause differences from expectations include the ability to secure allocations to refine product assortments to address consumer demand; the ability to renew leases in existing stores and control or lower occupancy costs, to open or close stores in the number and on the planned schedule, and to conduct required remodeling or refurbishment on schedule and at expected expense levels; our ability to realize anticipated cost savings, including rent savings; the timing and amount of any share repurchases by us; our ability to make our occupancy costs more variable; our ability to achieve expected digital gains and gain market share; changes in tax laws and tax rates and our ability to realize any anticipated tax benefits in both the amount and timeframe anticipated; deterioration in the performance of individual businesses or of our market value relative to our book value, resulting in impairments of fixed assets, operating lease right of use assets or intangible assets or other adverse financial consequences and the timing and amount of such impairments or other consequences; unexpected changes to the market for our shares or for the retail sector in general; costs and reputational harm as a result of disruptions in our business or information technology systems either by security breaches and incidents or by potential problems associated with the implementation of new or upgraded systems, and the cost and outcome of litigation, investigations, environmental matters and other disputes that involve us. For a full discussion of risk factors, see Part II, Item 1A, "Risk Factors" of this Quarterly Report on Form 10-Q.

Readers are cautioned not to place undue reliance on forward-looking statements as such statements speak only as of the date they were made and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The most important factors which could cause our actual results to differ from our forward-looking statements are set forth in our description of risk factors in Part I, Item 1A contained in our Annual Report on Form 10-K for the fiscal year ended February 1, 2025 which should be read in conjunction with the risk factors in Part II, Item 1A and the forward-looking statements in this Quarterly Report on Form 10-Q. Forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update any forward-looking statement.

The events described in the forward-looking statements might not occur or might occur to a different extent or at a different time than we have described. As a result, our actual results may differ materially from the results contemplated by these forward-looking statements.

We maintain a website at *www.genesco.com* where investors and other interested parties may obtain, free of charge, press releases and other information as well as gain access to our periodic filings with the Securities and Exchange Commission ("SEC"). The information contained on this website should not be considered to be a part of this or any other report filed with or furnished to the SEC.

------

**PART I - FINANCIAL INFORMATION**

**Item 1. Financial Statements (unaudited)**

**Genesco Inc. and Subsidiaries**

Condensed Consolidated Balance Sheets

(In thousands, except share amounts)

---

| | | | |
|:---|:---|:---|:---|
| **Assets** | **November 1, 2025** | February 1, 2025 | November 2, 2024 |
| ***Current Assets:*** |  |  |  |
| Cash and cash equivalents | $**27034** | $34007 | $33578 |
| Accounts receivable, net of allowances of $2,794 at November 1, 2025, |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;$2,522 at February 1, 2025 and $2,591 at November 2, 2024 | **55830** | 48865 | 52373 |
| Inventories | **558059** | 425224 | 523152 |
| Prepaids and other current assets | **48211** | 100660 | 50600 |
| Total current assets | **689134** | 608756 | 659703 |
| Property and equipment, net | **241070** | 228022 | 230090 |
| Operating lease right of use assets | **480247** | 438273 | 424886 |
| Non-current prepaid income taxes | **—** |  | 58670 |
| Goodwill | **9176** | 8863 | 9230 |
| Other intangibles | **27005** | 26059 | 27214 |
| Deferred income taxes | **389** | 389 | 339 |
| Other noncurrent assets | **25082** | 25174 | 25389 |
| **Total Assets** | **1472103** | 1335536 | 1435521 |
| **Liabilities and Equity** |  |  |  |
| ***Current Liabilities:*** |  |  |  |
| Accounts payable | **212668** | 168077 | 214935 |
| Current portion - long-term debt | **19727** |  |  |
| Current portion - operating lease liabilities | **120156** | 124010 | 123397 |
| Other accrued liabilities | **83412** | 87695 | 83750 |
| Total current liabilities | **435963** | 379782 | 422082 |
| Long-term debt | **69774** |  | 100114 |
| Long-term operating lease liabilities | **404009** | 361079 | 348672 |
| Other long-term liabilities | **48582** | 47705 | 47749 |
| Total liabilities | **958328** | 788566 | 918617 |
| Commitments and contingent liabilities | **—** |  |  |
| **Equity** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-redeemable preferred stock | **835** | 835 | 823 |
| &nbsp;&nbsp;&nbsp;&nbsp;Common equity: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock, $1 par value: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Authorized: 80,000,000 shares |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Issued common stock | **11281** | 11773 | 11701 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | **340723** | 331756 | 328760 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | **218286** | 265887 | 231997 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | **(39493)** | (45424) | (38520) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treasury shares, at cost (488,464 shares) | **(17857)** | (17857) | (17857) |
| Total equity | **513775** | 546970 | 516904 |
| **Total Liabilities and Equity** | $**1472103** | $1335536 | $1435521 |

---

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

------

**Genesco Inc. and Subsidiaries**

Condensed Consolidated Statements of Operations

(In thousands, except per share amounts)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **November 1, 2025** | November 2, 2024 | **November 1, 2025** | November 2, 2024 |
| Net sales | $**616217** | $596328 | $**1636155** | $1579113 |
| Cost of sales | **327589** | 311072 | **876397** | 831937 |
| Gross margin | **288628** | 285256 | **759758** | 747176 |
| Selling and administrative expenses | **275720** | 274912 | **789020** | 777878 |
| Asset impairments and other, net | **4332** | 134 | **4747** | 1490 |
| Operating income (loss) | **8576** | 10210 | **(34009)** | (32192) |
| Other components of net periodic benefit cost | **149** | 86 | **477** | 281 |
| Interest expense, net | **884** | 1213 | **3682** | 3448 |
| Earnings (loss) from continuing operations before income taxes | **7543** | 8911 | **(38168)** | (35921) |
| Income tax expense (benefit) | **2121** | 27759 | **(3922)** | 17144 |
| Earnings (loss) from continuing operations | **5422** | (18848) | **(34246)** | (53065) |
| Loss from discontinued operations, net of tax | **(66)** | (84) | **(96)** | (206) |
| **Net Earnings (Loss)** | $**5356** | $(18932) | $**(34342)** | $(53271) |
| Basic earnings (loss) per common share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | $**0.52** | $(1.76) | $**(3.30)** | $(4.88) |
| &nbsp;&nbsp;&nbsp;&nbsp;Discontinued operations | **0.00** | 0.00 | **(0.01)** | (0.02) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net earnings (loss) | $**0.52** | $(1.76) | $**(3.31)** | $(4.90) |
| Diluted earnings (loss) per common share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | $**0.51** | $(1.76) | $**(3.30)** | $(4.88) |
| &nbsp;&nbsp;&nbsp;&nbsp;Discontinued operations | **(0.01)** | 0.00 | **(0.01)** | (0.02) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net earnings (loss) | $**0.50** | $(1.76) | $**(3.31)** | $(4.90) |
| Weighted average shares outstanding: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | **10334** | 10737 | **10374** | 10870 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | **10674** | 10737 | **10374** | 10870 |

---

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

------

**Genesco Inc. and Subsidiaries**

Condensed Consolidated Statements of Comprehensive Income (Loss)

(In thousands)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **November 1, 2025** | November 2, 2024 | **November 1, 2025** | November 2, 2024 |
| Net earnings (loss) | $**5356** | $(18932) | $**(34342)** | $(53271) |
| Other comprehensive income: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Postretirement liability adjustments | **85** | 21 | **278** | 80 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation adjustments | **(1158)** | 625 | **5653** | 1024 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other comprehensive income (loss) | **(1073)** | 646 | **5931** | 1104 |
| **Comprehensive Income (Loss)** | $**4283** | $(18286) | $**(28411)** | $(52167) |

---

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

------

**Genesco Inc. and Subsidiaries**

Condensed Consolidated Statements of Cash Flows

(In thousands)

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended** | **Nine Months Ended** |
|  | **November 1, 2025** | November 2, 2024 |
| **CASH FLOWS FROM OPERATING ACTIVITIES:** |  |  |
| Net loss | $**(34342)** | $(53271) |
| Adjustments to reconcile net loss to net cash used in |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | **40228** | 39460 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | **626** | 26921 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairment of long-lived assets | **3896** | 494 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense | **9080** | 9767 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | **1379** | 724 |
| Changes in working capital and other assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | **(6943)** | 1371 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | **(128436)** | (143647) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaids and other current assets | **52972** | (10828) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | **46447** | 99322 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other accrued liabilities | **(8388)** | 6051 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets and liabilities | **(4116)** | (5472) |
| Net cash used in operating activities | **(27597)** | (29108) |
| **CASH FLOWS FROM INVESTING ACTIVITIES:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | **(52185)** | (27397) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from asset sales | **—** | 1 |
| Net cash used in investing activities | **(52185)** | (27396) |
| **CASH FLOWS FROM FINANCING ACTIVITIES:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Borrowings under revolving credit facility | **383390** | 344303 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments on revolving credit facility | **(294044)** | (278779) |
| &nbsp;&nbsp;&nbsp;&nbsp;Shares repurchased related to share repurchase plan | **(12566)** | (9789) |
| &nbsp;&nbsp;&nbsp;&nbsp;Shares repurchased related to taxes for share-based awards | **(1206)** | (2074) |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in overdraft balances | **(3129)** | 882 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additions to deferred financing costs | **(10)** |  |
| Net cash provided by financing activities | **72435** | 54543 |
| Effect of foreign exchange rate fluctuations on cash | **374** | 384 |
| **Net decrease in cash and cash equivalents** | **(6973)** | (1577) |
| Cash and cash equivalents at beginning of period | **34007** | 35155 |
| **Cash and cash equivalents at end of period** | $**27034** | $33578 |
| Supplemental information: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest paid | $**3359** | $3290 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes paid (received) | **(56141)** | 2275 |

---

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

------

**Genesco Inc. and Subsidiaries**

Condensed Consolidated Statements of Equity

(In thousands)

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Non-<br>Redeemable<br>Preferred<br>Stock | Common<br>Stock | Additional<br>Paid-In<br>Capital | Retained<br>Earnings | Accumulated<br>Other<br>Comprehensive<br>Loss | Treasury<br>Shares | Total<br>Equity |
| Balance February 3, 2024 | $813 | $11961 | $319143 | $296766 | $(39624) | $(17857) | $571202 |
| Net loss |  |  |  | (24347) |  |  | (24347) |
| Other comprehensive loss |  |  |  |  | (935) |  | (935) |
| Share-based compensation expense |  |  | 3307 |  |  |  | 3307 |
| Restricted stock issuance |  | 198 | (198) |  |  |  |  |
| Restricted shares withheld for taxes |  | (29) | 29 | (773) |  |  | (773) |
| Other | (1) | (8) | 7 | 1 |  |  | (1) |
| Balance May 4, 2024 | 812 | 12122 | 322288 | 271647 | (40559) | (17857) | 548453 |
| Net loss |  |  |  | (9992) |  |  | (9992) |
| Other comprehensive income |  |  |  |  | 1393 |  | 1393 |
| Share-based compensation expense |  |  | 3453 |  |  |  | 3453 |
| Restricted stock issuance |  | 37 | (37) |  |  |  |  |
| Shares repurchased |  | (382) |  | (8967) |  |  | (9349) |
| Excise taxes related to repurchases of common stock |  |  |  | (35) |  |  | (35) |
| Restricted shares withheld for taxes |  | (49) | 49 | (1301) |  |  | (1301) |
| Other |  | (21) | 22 | (1) |  |  |  |
| Balance August 3, 2024 | 812 | 11707 | 325775 | 251351 | (39166) | (17857) | 532622 |
| Net loss |  |  |  | (18932) |  |  | (18932) |
| Other comprehensive income |  |  |  |  | 646 |  | 646 |
| Share-based compensation expense |  |  | 3007 |  |  |  | 3007 |
| Restricted stock issuance |  | 15 | (15) |  |  |  |  |
| Shares repurchased |  | (18) |  | (421) |  |  | (439) |
| Other | 11 | (3) | (7) | (1) |  |  |  |
| Balance November 2, 2024 | $823 | $11701 | $328760 | $231997 | $(38520) | $(17857) | $516904 |
|  | Non-<br>Redeemable<br>Preferred<br>Stock | Common<br>Stock | Additional<br>Paid-In<br>Capital | Retained<br>Earnings | Accumulated<br>Other<br>Comprehensive<br>Loss | Treasury<br>Shares | Total<br>Equity |
| Balance February 1, 2025 | $835 | $11773 | $331756 | $265887 | $(45424) | $(17857) | $546970 |
| Net loss |  |  |  | (21227) |  |  | (21227) |
| Other comprehensive income |  |  |  |  | 6724 |  | 6724 |
| Share-based compensation expense |  |  | 2994 |  |  |  | 2994 |
| Restricted stock issuance |  | 141 | (141) |  |  |  |  |
| Restricted shares withheld for taxes |  | (36) | 36 | (664) |  |  | (664) |
| Shares repurchased |  | (605) |  | (11961) |  |  | (12566) |
| Other |  | (5) | 6 |  |  |  | 1 |
| Balance May 3, 2025 | 835 | 11268 | 334651 | 232035 | (38700) | (17857) | 522232 |
| Net loss |  |  |  | (18471) |  |  | (18471) |
| Other comprehensive income |  |  |  |  | 280 |  | 280 |
| Share-based compensation expense |  |  | 2918 |  |  |  | 2918 |
| Restricted stock issuance |  | 45 | (45) |  |  |  |  |
| Excise taxes related to repurchases of common stock |  |  |  | (92) |  |  | (92) |
| Restricted shares withheld for taxes |  | (24) | 24 | (495) |  |  | (495) |
| Other |  | (4) | 4 |  |  |  |  |
| Balance August 2, 2025 | 835 | 11285 | 337552 | 212977 | (38420) | (17857) | 506372 |
| Net earnings |  |  |  | 5356 |  |  | 5356 |
| Other comprehensive loss |  |  |  |  | (1073) |  | (1073) |
| Share-based compensation expense |  |  | 3167 |  |  |  | 3167 |
| Restricted shares withheld for taxes |  | (2) | 2 | (47) |  |  | (47) |
| Other |  | (2) | 2 |  |  |  |  |
| **Balance November 1, 2025** | $**835** | $**11281** | $**340723** | $**218286** | $**(39493)** | $**(17857)** | $**513775** |

---

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

------

**Genesco Inc. and Subsidiaries**

**Notes to Condensed Consolidated Financial Statements (unaudited)**

**Note 1**

**<u>Summary of Sig</u><u>nificant Accounting Policies</u>**

***Basis of Presentation***

These Condensed Consolidated Financial Statements should be read in conjunction with our Consolidated Financial Statements and Notes for Fiscal 2025, which are contained in our Annual Report on Form 10-K as filed with the SEC on March 26, 2025. The Condensed Consolidated Financial Statements and Notes contained in this report are unaudited but reflect all adjustments, including normal recurring adjustments, necessary for a fair presentation of the results for the interim periods of the fiscal year ending January 31, 2026 ("Fiscal 2026") and of the fiscal year ended February 1, 2025 ("Fiscal 2025"), both of which are 52-week years. All subsidiaries are consolidated in the Condensed Consolidated Financial Statements. All significant intercompany transactions and accounts have been eliminated. The results of operations for any interim period are not necessarily indicative of results for the full year. The Condensed Consolidated Financial Statements and the related Notes have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and notes required by U.S. Generally Accepted Accounting Principles ("GAAP") for complete financial statements. The Condensed Consolidated Balance Sheet as of February 1, 2025 has been derived from the audited financial statements at that date.

***Nature of Operations***

Genesco Inc. and its subsidiaries (collectively the "Company", "Genesco," "we", "our", or "us") business includes the sourcing and design, marketing and distribution of footwear, apparel and accessories through retail stores in the U.S., Puerto Rico and Canada primarily under the Journeys<sup>®</sup>, Journeys Kidz<sup>®</sup>, Little Burgundy<sup>®</sup> and Johnston & Murphy<sup>®</sup> banners and under the Schuh<sup>®</sup> banner in the United Kingdom ("U.K.") and the Republic of Ireland ("ROI"); through e-commerce websites including the following: journeys.com, journeyskidz.com, journeys.ca, littleburgundyshoes.com, schuh.co.uk, schuh.ie, schuh.eu, johnstonmurphy.com and nashvilleshoewarehouse.com as well as the Johnston & Murphy catalog. We also source, design, market and distribute footwear, apparel and accessories at wholesale, primarily under our Johnston & Murphy brand, the licensed Levi's<sup>®</sup> brand, the licensed Dockers<sup>®</sup> brand and other brands that we license for footwear. At November 1, 2025, we operated 1,245 retail stores in the U.S., Puerto Rico, Canada, the U.K. and the ROI.

During the three and nine months ended November 1, 2025 and November 2, 2024, we operated four reportable business segments (not including corporate): (i) Journeys Group, comprised of the Journeys, Journeys Kidz and Little Burgundy retail footwear chains and e-commerce operations; (ii) Schuh Group, comprised of the Schuh retail footwear chain and e-commerce operations; (iii) Johnston & Murphy Group, comprised of Johnston & Murphy retail operations, e-commerce operations and wholesale distribution of products under the Johnston & Murphy brand; and (iv) Genesco Brands Group, comprised of the licensed Dockers and Levi's brands, as well as other brands we license for footwear. Our license with Levi's expires in the spring of 2026 and we are in the process of exiting that business during Fiscal 2026.

During the second quarter of Fiscal 2026, we signed a multi-year licensing agreement with Kontoor Brands, Inc. to design, source, market and distribute men's, women's and children's footwear under the Wrangler<sup>®</sup> brand ("Wrangler"). We expect to launch the first Wrangler footwear collection under the licensing agreement in the Fall of 2026.

***Selling and Administrative Expenses***

Wholesale costs of distribution are included in selling and administrative expenses on the Condensed Consolidated Statements of Operations in the amount of $2.6 million and $2.4 million for the third quarters of Fiscal 2026 and Fiscal 2025, respectively, and $7.9 million and $7.4 million for the first nine months of Fiscal 2026 and Fiscal 2025, respectively.

Retail occupancy costs recorded in selling and administrative expenses were $74.4 million and $75.7 million for the third quarters of Fiscal 2026 and Fiscal 2025, respectively, and $220.8 million and $224.7 million for the first nine months of Fiscal 2026 and Fiscal 2025, respectively.

***Advertising Costs***

Advertising costs included in selling and administrative expenses were $37.1 million and $36.6 million for the third quarters of Fiscal 2026 and Fiscal 2025, respectively, and $92.1 million and $88.0 million for the first nine months of Fiscal 2026 and Fiscal 2025, respectively.

***Vendor Allowances***

Vendor reimbursements of cooperative advertising costs recognized as a reduction of selling and administrative expenses were $3.0 million and $3.1 million for the third quarters of Fiscal 2026 and Fiscal 2025, respectively, and $10.2 million and $7.7 million for the first nine months of

------

**Genesco Inc. and Subsidiaries**

**Notes to Condensed Consolidated Financial Statements (unaudited)**

**Note 1**

**<u>Summary of Significant Accounting Policies, Continued</u>**

Fiscal 2026 and Fiscal 2025, respectively. During the first nine months of each of Fiscal 2026 and Fiscal 2025, our cooperative advertising reimbursements received were not in excess of the costs incurred.

***New Accounting Pronouncements***

*New Accounting Pronouncement Not Yet Adopted*

In September 2025, the Financial Accounting Standards Board issued Accounting Standards Update ("ASU") 2025-06, "Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)." The ASU is intended to modernize the accounting for internal-use software costs with how software is developed today, clarify when to begin capitalizing costs and enhance disclosure requirements. The ASU is effective on either a retrospective, prospective or modified prospective basis for fiscal years beginning after December 15, 2027, including interim periods within those fiscal years. Early adoption is permitted. We are currently evaluating the impact of the adoption of this ASU on our annual consolidated financial statements and interim condensed consolidated financial statements.

We continuously monitor and review all current accounting pronouncements and standards from the Financial Accounting Standards Board of U.S. GAAP for applicability to our operations and financial reporting. As of November 1, 2025, there were no other new pronouncements or interpretations, other than those disclosed above and in our Annual Report on Form 10-K for the fiscal year ended February 1, 2025, that had or were expected to have a significant impact on our financial reporting.

***Recent Tax Legislation***

On July 4, 2025, H.R. 1, a bill to provide for reconciliation pursuant to title II of H. Con. Res. 14, informally known as the One Big Beautiful Bill Act ("OBBBA"), which includes several measures affecting corporations and other business entities, was signed into law. Among these measures, the OBBBA modifies and permanently extends certain expiring provisions of the 2017 Tax Cuts and Jobs Act ("TCJA"), including the restoration of 100% bonus depreciation, which was scheduled to phase out in 2027 under the TCJA. The OBBBA also permits immediate expensing of research and development expenditures previously capitalized under the TCJA and modifies various components of the international tax framework. The legislation has multiple effective dates, with some provisions taking effect in 2025 and others phased in through 2027. In accordance with Accounting Standards Codification ("ASC") 740, *"Income Taxes,"* we recognized effects of the OBBBA during the second quarter of Fiscal 2026 for the provisions enacted at that point in time. For the fiscal year ending January 31, 2026, we anticipate a material decrease in our U.S. jurisdiction to both the current tax liability and the effective income tax rate as a result of the enactment of income tax law changes under the OBBBA and their interaction with our valuation allowance in the U.S. jurisdiction. Including the impact of the OBBBA tax law changes, we recorded an effective income tax rate of 10.3% in the first nine months of Fiscal 2026.

**Note 2**

**<u>Goodwill and Other Intangible Assets</u>**

The changes in the carrying amount of goodwill for the Journeys Group segment were as follows:

---

| | |
|:---|:---|
| (In thousands) | Total<br>Goodwill |
| Balance, February 1, 2025 | $8863 |
| Effect of foreign currency exchange rates | 313 |
| **Balance, November 1, 2025** | $**9176** |

---

------

**Genesco Inc. and Subsidiaries**

**Notes to Condensed Consolidated Financial Statements (unaudited)**

**Note 2**

**<u>Goodwill and Other Intangible Assets, Continued</u>**

Other intangibles by major classes were as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Trademarks | Trademarks | Customer Lists | Customer Lists | Other | Other | Total | Total |
| (In thousands) | **Nov. 1, 2025** | Feb. 1, 2025 | **Nov. 1, 2025** | Feb. 1, 2025 | **Nov. 1, 2025** | Feb. 1, 2025 | **Nov. 1, 2025** | Feb. 1, 2025 |
| Gross other intangibles | $**25210** | $23839 | $**6552** | $6471 | $**400** | $400 | $**32162** | $30710 |
| Accumulated amortization | **—** |  | **(4757)** | (4251) | **(400)** | (400) | **(5157)** | (4651) |
| **Net Other Intangibles** | $**25210** | $23839 | $**1795** | $2220 | $**—** | $— | $**27005** | $26059 |

---

**Note 3**

**<u>Inventories</u>**

---

| | | |
|:---|:---|:---|
| (In thousands) | **November 1, 2025** | February 1, 2025 |
| Wholesale finished goods | $**64357** | $82784 |
| Retail merchandise | **493702** | 342440 |
| **Total Inventories** | $**558059** | $425224 |

---

**Note 4**

**<u>Fair Value</u>**

***Fair Value of Financial Instruments***

The carrying amounts and fair values of our financial instruments at November 1, 2025 and February 1, 2025 are:

---

| | | | | |
|:---|:---|:---|:---|:---|
| (In thousands) | **November 1, 2025** | **November 1, 2025** | February 1, 2025 | February 1, 2025 |
|  | **Carrying<br>Amount** | **Fair<br>Value** | Carrying<br>Amount | Fair<br>Value |
| U.S. Revolver Borrowings | $**69774** | $**69795** | $— | $— |
| U.K. Revolver Borrowings | **19727** | **19737** |  |  |
| Total Long-Term Debt | $**89501** | $**89532** | $— | $— |

---

Debt fair values were determined using a discounted cash flow analysis based on current market interest rates for similar types of financial instruments and would be classified in Level 2 within the fair value hierarchy. We had $19.7 million of debt classified as current portion as of November 1, 2025 and no debt classified as current portion as of February 1, 2025.

As of November 1, 2025, we had $6.9 million of long-lived assets held and used which were measured using Level 3 inputs within the fair value hierarchy. As of November 1, 2025, we had $6.9 million of investments held and used which were measured using Level 1 inputs within the fair value hierarchy.

------

**Genesco Inc. and Subsidiaries**

**Notes to Condensed Consolidated Financial Statements (unaudited)**

**Note 5**

**<u>Long-Term Debt</u>**

The revolver borrowings outstanding under the Fourth Amended and Restated Credit Agreement dated as of January 31, 2018, as amended, between us, certain of our subsidiaries, the lenders party thereto and Bank of America, N.A. as agent (the "Credit Facility") as of November 1, 2025 included (i) $65.0 million U.S. revolver borrowings and (ii) $4.8 million (CAD $6.7 million) revolver borrowings related to GCO Canada ULC. In addition, we had revolver borrowings outstanding by and between Schuh and Lloyds Bank PLC (the "Facility Agreement") of $19.7 million (£15.0 million) as of November 1, 2025. The Facility Agreement was extended through February 28, 2026. We were in compliance with all the relevant terms and conditions of the Credit Facility and Facility Agreement as of November 1, 2025. Excess availability under the Credit Facility was $256.5 million at November 1, 2025.

**Note 6**

**<u>Earnings Per Share</u>**

Weighted-average number of shares used to calculate earnings per share are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| (Shares in thousands) | **November 1, 2025** | November 2, 2024 | **November 1, 2025** | November 2, 2024 |
| Weighted-average number of shares - basic | **10334** | 10737 | **10374** | 10870 |
| Common stock equivalents | **340** | - | **-** | - |
| Weighted-average number of shares - diluted | **10674** | 10737 | **10374** | 10870 |

---

Common stock equivalents of 0.1 million shares are excluded for the three months ended November 2, 2024 and 0.2 million shares are excluded for each of the nine months ended November 1, 2025 and November 2, 2024 due to the loss from continuing operations in those periods.

We did not repurchase any shares of our common stock during the third quarter of Fiscal 2026. We repurchased 604,531 shares of our common stock during the first nine months of Fiscal 2026 at a cost of $12.6 million, or an average cost of $20.79 per share. As of November 1, 2025, we had $29.8 million remaining under our expanded share repurchase authorization announced in June 2023. We repurchased 17,922 shares of our common stock during the third quarter of Fiscal 2025 at a cost of $0.4 million, or an average cost of $24.50 per share, and repurchased 399,633 shares of common stock during the first nine months of Fiscal 2025 at a cost of $9.8 million, or an average cost of $24.49 per share. During the fourth quarter of Fiscal 2026, through December 11, 2025, we have not repurchased any shares of our common stock.

**Note 7**

**<u>Legal Proceedings</u>** 

**Environmental Matters**

The Company has legacy obligations including environmental monitoring and reporting costs related to: (i) a 2016 Consent Judgment entered into with the United States Environmental Protection Agency involving the site of a knitting mill operated by a former subsidiary from 1965 to 1969 in Garden City, New York; and (ii) a 2010 Consent Decree with the Michigan Department of Natural Resources and Environment relating to our former Volunteer Leather Company facility in Whitehall, Michigan. We do not expect that future obligations related to either of these sites will have a material effect on our consolidated financial condition or results of operations.

*Accrual for Environmental Contingencies*

Related to all outstanding environmental contingencies, we had accrued $2.0 million as of November 1, 2025, $2.1 million as of February 1, 2025 and $1.9 million as of November 2, 2024. All such provisions reflect our estimates of the most likely cost (undiscounted, including both current and noncurrent portions) of resolving the contingencies, based on facts and circumstances as of the time they were made. There is no assurance that relevant facts and circumstances will not change, necessitating future changes to the provisions. Such contingent liabilities for discontinued operations are included in other accrued liabilities and other long-term liabilities on the accompanying Condensed Consolidated Balance Sheets because they relate to former facilities operated by us. We have made pretax accruals for certain of these contingencies which were not material for the third quarter of Fiscal 2026 or Fiscal 2025. These charges are included in loss from discontinued operations, net of tax in the Condensed Consolidated Statements of Operations and represent changes in estimates.

------

**Genesco Inc. and Subsidiaries**

**Notes to Condensed Consolidated Financial Statements (unaudited)**

**Note 7**

**<u>Legal Proceedings, Continued</u>**

In addition to the matters specifically described in this Note, we are a party to other legal and regulatory proceedings and claims arising in the ordinary course of our business. While management does not believe that our liability with respect to any of these other matters is likely to have a material effect on our Condensed Consolidated Financial Statements, legal proceedings are subject to inherent uncertainties, and unfavorable rulings could have a material adverse impact on our Condensed Consolidated Financial Statements.

**Note 8**

**<u>Business Segment Information</u>**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Three Months Ended November 1, 2025** |  |  |  |  |  |  |
| **(**In thousands) | **Journeys<br>Group** | **Schuh<br>Group** | **Johnston<br>& Murphy<br>Group** | **Genesco Brands Group** | **Corporate<br>& Other** | **Consolidated** |
| Sales | **$376707** | **$123766** | **$81157** | **$34587** | **$—** | **$616217** |
| Intercompany sales elimination | **—** | **—** | **—** | **—** | **—** | **—** |
| **Net sales to external customers**<sup>(1)</sup> | **376707** | **123766** | **81157** | **34587** | **—** | **616217** |
| Cost of sales | **190436** | **72095** | **38207** | **26851** | **—** | **327589** |
| Gross margin | **186271** | **51671** | **42950** | **7736** | **—** | **288628** |
| Selling and administrative expenses | **165705** | **51002** | **43545** | **7195** | **8273** | **275720** |
| Segment operating income (loss) | **20566** | **669** | **(595)** | **541** | **(8273)** | **12908** |
| Asset impairments and other<sup>(2)</sup> | **—** | **—** | **—** | **—** | **4332** | **4332** |
| **Operating income (loss)** | **20566** | **669** | **(595)** | **541** | **(12605)** | **8576** |
| Other components of net periodic benefit cost | **—** | **—** | **—** | **—** | **149** | **149** |
| Interest expense, net | **—** | **—** | **—** | **—** | **884** | **884** |
| **Earnings (loss) from continuing operations before income taxes** | **$20566** | **$669** | **$(595)** | **$541** | **$(13638)** | **$7543** |
| Total assets <sup>(3)</sup> | **$826248** | **$226909** | **$212920** | **$57107** | **$148919** | **$1472103** |
| Depreciation and amortization | **8258** | **2054** | **1783** | **349** | **917** | **13361** |
| Capital expenditures | **12637** | **1547** | **4096** | **60** | **265** | **18605** |

---

<sup>(1)</sup> Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales in the third quarter of Fiscal 2026.

<sup>(2)</sup> Asset impairments and other includes a $3.9 million charge for store restructuring, including $3.6 million in Journeys Group and $0.3 million in Schuh Group, $0.2 million for severance and $0.2 million for asset impairments in Schuh Group.

<sup>(3)</sup> Of our $721.3 million of long-lived assets as of November 1, 2025, $91.1 million and $14.6 million relate to long-lived assets in the U.K. and Canada, respectively.

------

**Genesco Inc. and Subsidiaries**

**Notes to Condensed Consolidated Financial Statements (unaudited)**

**Note 8**

**<u>Business Segment Information, Continued</u>**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Three Months Ended November 2, 2024** |  |  |  |  |  |  |
| **(**In thousands) | **Journeys<br>Group** | **Schuh<br>Group** | **Johnston<br>& Murphy<br>Group** | **Genesco Brands Group** | **Corporate<br>& Other** | **Consolidated** |
| Sales | $362517 | $121826 | $78463 | $33587 | $— | $596393 |
| Intercompany sales elimination |  |  |  | (65) |  | (65) |
| **Net sales to external customers**<sup>(1)</sup> | 362517 | 121826 | 78463 | 33522 |  | 596328 |
| Cost of sales | 184068 | 69477 | 35895 | 21632 |  | 311072 |
| Gross margin | 178449 | 52349 | 42568 | 11890 | **—** | 285256 |
| Selling and administrative expenses | 165283 | 49230 | 42659 | 8161 | 9579 | 274912 |
| Segment operating income (loss) | 13166 | 3119 | (91) | 3729 | (9579) | 10344 |
| Asset impairments and other <sup>(2)</sup> |  |  |  |  | 134 | 134 |
| **Operating income (loss)** | 13166 | 3119 | (91) | 3729 | (9713) | 10210 |
| Other components of net periodic benefit cost |  |  |  |  | 86 | 86 |
| Interest expense, net |  |  |  |  | 1213 | 1213 |
| **Earnings (loss) from continuing operations before income taxes** | $13166 | $3119 | $(91) | $3729 | $(11012) | $8911 |
| Total assets <sup>(3)</sup> | $746432 | $215531 | $178166 | $69478 | $225914 | $1435521 |
| Depreciation and amortization | 8385 | 1944 | 1358 | 337 | 1030 | 13054 |
| Capital expenditures | 6255 | 3109 | 3561 | 108 | 90 | 13123 |

---

<sup>(1)</sup> Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales for the third quarter of Fiscal 2025.

<sup>(2)</sup> Asset impairments and other includes a $0.1 million charge for asset impairments in Journeys Group.

<sup>(3)</sup> Of our $655.0 million of long-lived assets as of November 2, 2024, $93.7 million and $9.8 million relate to long-lived assets in the U.K. and Canada, respectively.

------

**Genesco Inc. and Subsidiaries**

**Notes to Condensed Consolidated Financial Statements (unaudited)**

**Note 8**

**<u>Business Segment Information, Continued</u>**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Nine Months Ended November 1, 2025** |  |  |  |  |  |  |
| **<br>(In thousands)** | **Journeys<br>Group** | **Schuh<br>Group** | **Johnston<br>& Murphy<br>Group** | **Genesco Brands Group** | **Corporate<br>& Other** | **Consolidated** |
| Sales | **$967530** | **$346276** | **$226785** | **$95564** | **$—** | **$1636155** |
| Intercompany sales elimination | **—** | **—** | **—** | **—** | **—** | **—** |
| **Net sales to external customers**<sup>(1)</sup> | **967530** | **346276** | **226785** | **95564** | **—** | **1636155** |
| Cost of sales | **492712** | **207245** | **105540** | **70900** | **—** | **876397** |
| Gross margin | **474818** | **139031** | **121245** | **24664** | **—** | **759758** |
| Selling and administrative expenses | **474534** | **144504** | **123122** | **22772** | **24088** | **789020** |
| Segment operating income (loss) | **284** | **(5473)** | **(1877)** | **1892** | **(24088)** | **(29262)** |
| Asset impairments and other<sup>(2)</sup> |  |  |  |  | **4747** | **4747** |
| **Operating income (loss)** | **284** | **(5473)** | **(1877)** | **1892** | **(28835)** | **(34009)** |
| Other components of net periodic benefit cost |  |  |  |  | **477** | **477** |
| Interest expense, net |  |  |  |  | **3682** | **3682** |
| **Earnings (loss) from continuing<br> operations before income taxes** | **$284** | **$(5473)** | **$(1877)** | **$1892** | **$(32994)** | **$(38168)** |
| Depreciation and amortization | **$24841** | **$6107** | **$5263** | **$1037** | **$2980** | **$40228** |
| Capital expenditures | **30739** | **7521** | **13104** | **200** | **621** | **52185** |

---

<sup>(1)</sup> Net sales in North America and in the U.K., which includes the ROI, accounted for 79% and 21%, respectively, of our net sales for the first nine months of Fiscal 2026.

<sup>(2)</sup> Asset impairments and other includes a $3.9 million charge for store restructuring, including $3.6 million in Journeys Group and $0.3 million in Schuh Group, $0.6 million for severance and $0.2 million for asset impairments in Schuh Group.

------

**Genesco Inc. and Subsidiaries**

**Notes to Condensed Consolidated Financial Statements (unaudited)**

**Note 8**

**<u>Business Segment Information, Continued</u>**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Nine Months Ended November 2, 2024** |  |  |  |  |  |  |
| **<br>(In thousands)** | **Journeys<br>Group** | **Schuh<br>Group** | **Johnston<br>& Murphy<br>Group** | **Genesco Brands Group** | **Corporate<br>& Other** | **Consolidated** |
| Sales | $920808 | $338736 | $228707 | $88941 | $— | $1577192 |
| Intercompany sales elimination<sup>(1)</sup> |  |  |  | 1921 |  | 1921 |
| **Net sales to external customers**<sup>(2)</sup> | 920808 | 338736 | 228707 | 90862 |  | $1579113 |
| Cost of sales | 469486 | 195777 | 106277 | 60397 |  | 831937 |
| Gross margin | 451322 | 142959 | 122430 | 30465 | **—** | 747176 |
| Selling and administrative expenses | 468129 | 138397 | 120569 | 25050 | 25733 | 777878 |
| Segment operating income (loss) | (16807) | 4562 | 1861 | 5415 | (25733) | (30702) |
| Asset impairments and other<sup>(3)</sup> |  |  |  |  | 1490 | 1490 |
| **Operating income (loss)** | (16807) | 4562 | 1861 | 5415 | (27223) | (32192) |
| Other components of net periodic benefit cost |  |  |  |  | 281 | 281 |
| Interest expense |  |  |  |  | 3448 | 3448 |
| **Earnings (loss) from continuing<br> operations before income taxes** | $(16807) | $4562 | $1861 | $5415 | $(30952) | $(35921) |
| Depreciation and amortization | $25545 | $5662 | $4136 | $982 | $3135 | $39460 |
| Capital expenditures | 14059 | 5606 | 6737 | 643 | 352 | 27397 |

---

<sup>(1)</sup> Intercompany sales for the first nine months of Fiscal 2025 reflect net intercompany returns.

<sup>(2)</sup> Net sales in North America and in the U.K., which includes the ROI, accounted for 79% and 21% respectively, of our net sales for the first nine months of Fiscal 2025.

<sup>(3)</sup> Asset impairments and other includes a $0.5 million charge for asset impairments in Journeys Group and $1.0 million for severance.

------

**<u>Item 2. Management's Discussion and</u> <u>Analysis of Financial Condition and Results of Operations</u>**

This section discusses management's view of the financial condition, results of operations and cash flows of the Company. This section should be read in conjunction with the information contained in our Annual Report on Form 10-K for the fiscal year ended February 1, 2025, including the Risk Factors section, and information contained elsewhere in this Quarterly Report on Form 10-Q, including the Condensed Consolidated Financial Statements and Notes to those financial statements. The results of operations for any interim period may not necessarily be indicative of the results that may be expected for any future interim period or the entire fiscal year.

**Summary of Results of Operations**

Our net sales increased 3.3% to $616.2 million in the third quarter of Fiscal 2026 compared to $596.3 million in the third quarter of Fiscal 2025. The net sales increase compared to last year's third quarter reflects a 3% increase in comparable sales, including a 5% increase in same store sales reflecting investment in and a strategic focus on the store channel as well as strong back-to-school sales in Journeys Group, an increase in wholesale sales and a favorable foreign exchange impact, partially offset by the impact of net store closings resulting from our store optimization efforts. The Journeys Group business had a strong third quarter of Fiscal 2026 with comparable sales up 6%, fueled by strength in the product assortment and other initiatives. Schuh Group comparable sales were down 2% for the third quarter of Fiscal 2026 reflecting the challenging retail environment in the U.K. Johnston & Murphy Group comparable sales were down 2% in the third quarter of Fiscal 2026 driven by softer e-commerce trends due to a shift in marketing spend. By segment, Journeys Group sales increased 4%, Schuh Group sales increased 2%, Johnston & Murphy Group sales increased 3% with higher wholesale sales offsetting the lower comparable sales and Genesco Brands Group sales increased 3% in the third quarter of Fiscal 2026 compared to the third quarter of Fiscal 2025. Schuh Group's sales decreased 1% on a local currency basis for the third quarter of Fiscal 2026.

Gross margin increased 1.2% to $288.6 million in the third quarter of Fiscal 2026 from $285.3 million in the third quarter of Fiscal 2025, but decreased as a percentage of net sales from 47.8% in the third quarter of Fiscal 2025 to 46.8% in the third quarter of Fiscal 2026. The overall decrease in gross margin as a percentage of net sales is due primarily to lower margins at Genesco Brands Group related to ongoing tariff pressure and the exit of licenses as well as increased promotional activity at Schuh Group, partially offset by lower shipping and warehouse costs for Journeys Group and Schuh Group.

Selling and administrative expenses in the third quarter of Fiscal 2026 increased 0.3% to $275.7 million from $274.9 million compared to the third quarter of Fiscal 2025, but decreased 140 basis points as a percentage of net sales in the third quarter of Fiscal 2026 compared to the third quarter of Fiscal 2025 from 46.1% to 44.7%. The decrease as a percentage of net sales reflects decreased occupancy, freight and performance-based compensation expenses.

Operating margin was 1.4% in the third quarter of Fiscal 2026 compared to 1.7% in the third quarter of Fiscal 2025. The overall decrease in operating margin for the third quarter of Fiscal 2026 compared to the third quarter of Fiscal 2025 primarily reflects decreased gross margin as a percentage of net sales and higher asset impairment and other charges, partially offset by decreased expenses as a percentage of net sales.

Earnings from continuing operations before income taxes ("pretax earnings") for the third quarter of Fiscal 2026 was $7.5 million compared to $8.9 million for the third quarter of Fiscal 2025. Pretax earnings for the third quarter of Fiscal 2026 included asset impairment and other charges of $4.3 million for store restructuring, severance and asset impairments. Pretax earnings for the third quarter of Fiscal 2025 included a $0.1 million charge for asset impairments.

We had an effective income tax rate of 28.1% and 311.5% in the third quarter of Fiscal 2026 and Fiscal 2025, respectively. The lower effective tax rate in the third quarter of Fiscal 2026 compared to the third quarter of Fiscal 2025 primarily reflects a $26.3 million U.S. valuation allowance recorded in the third quarter of Fiscal 2025.

Net earnings in the third quarter of Fiscal 2026 was $5.4 million, or $0.50 diluted earnings per share, compared to a net loss of $18.9 million, or $1.76 diluted loss per share, in the third quarter of Fiscal 2025.

**Critical Accounting Estimates**

We discuss our critical accounting estimates in Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations", in our Annual Report on Form 10-K for the fiscal year ended February 1, 2025. We describe our significant accounting policies in Note 1, "Summary of Significant Accounting Policies", of the Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended February 1, 2025. There have been no significant changes in our definition of significant accounting policies or critical accounting estimates since the end of Fiscal 2025.

------

**Key Performance Indicators**

In assessing the performance of our business, we consider a variety of performance and financial measures. The key performance indicators we use to evaluate the financial condition and operating performance of our business are comparable sales, net sales, gross margin, operating income and operating margin. These key performance indicators should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the U.S. GAAP financial measures presented herein. These measures may not be comparable to similarly titled performance indicators used by other companies.

**Comparable Sales**

We consider comparable sales to be an important indicator of our current performance, and investors may find it useful as such. Comparable sales results are important to achieve leveraging of our costs, including occupancy, selling salaries, depreciation and other costs. Comparable sales also have a direct impact on our total net revenue, working capital and cash. We define "comparable sales" as sales from stores open longer than one year, beginning with the first day a store has comparable sales (which we refer to as "same store sales"), and sales from websites operated longer than one year and direct mail catalog sales (which we refer to in this report as "comparable e-commerce sales"). Temporarily closed stores are excluded from the comparable sales calculation if closed for more than seven days. Expanded stores are excluded from the comparable sales calculation until the first day an expanded store has comparable prior year sales. Current year foreign exchange rates are applied to both current year and prior year comparable sales to achieve a consistent basis for comparison.

**Operating Margin**

Operating margin is a ratio calculated by dividing operating income (loss) by net sales. We believe operating margin provides investors with useful information related to the profitability of our business after considering all of the selling, general and administrative expenses and other operating charges incurred. We use this measure in making financial, operating and planning decisions and in evaluating our overall performance.

**Results of Operations – Third Quarter of Fiscal 2026 Compared to Third Quarter of Fiscal 2025**

*Journeys Group*

---

| | | | |
|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** |  |
|  | **November 1, 2025** | November 2, 2024 | %<br>Change |
|  | (dollars in thousands) | (dollars in thousands) |  |
| Net sales | **$376707** | $362517 | 3.9% |
| Cost of sales | **190436** | 184068 |  |
| Gross margin | **186271** | 178449 | 4.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;% of sales | ***49.4%*** | *49.2%* |  |
| Selling and administrative expenses | **165705** | 165283 | 0.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;% of sales | ***44.0%*** | *45.6%* |  |
| Operating income | **$20566** | $13166 | 56.2% |
| Operating margin | ***5.5%*** | *3.6%* |  |

---

Net sales from Journeys Group increased 3.9% to $376.7 million in the third quarter of Fiscal 2026, compared to $362.5 million in the third quarter of Fiscal 2025. The net sales increase compared to the third quarter of Fiscal 2025 reflects an increase in same store sales, partially offset by a 5% decrease in the average number of stores in the third quarter of Fiscal 2026 and a decrease in e-commerce comparable sales. The increased comparable sales in the third quarter of Fiscal 2026 was fueled by the continued strength in Journeys Group's product assortment and other initiatives. The Journeys Group consumer is more interested in a broader range of brands evidenced by what they are buying and by the more diversified styles they are wearing. Journeys Group's strong store performance was driven by gains in conversion and higher transaction size in the third quarter of Fiscal 2026.

We closed ten Journeys Group stores in the third quarter of Fiscal 2026. Journeys Group operated 974 stores at the end of the third quarter of Fiscal 2026, including 196 Journeys Kidz stores in the United States, 33 Journeys stores in Canada and 30 Little Burgundy stores in Canada, compared to 1,028 stores at the end of the third quarter of Fiscal 2025, including 218 Journeys Kidz stores in the United States, 37 Journeys stores in Canada and 30 Little Burgundy stores in Canada.

The 190 basis point improvement in operating margin for Journeys Group for the third quarter of Fiscal 2026 compared to the third quarter of Fiscal 2025 was primarily due to a 160 basis point decrease in selling and administrative expenses as a percentage of net sales. This reflects leverage of expenses as a result of increased revenue in the third quarter of Fiscal 2026, especially occupancy expense and selling salaries, partially offset by increased marketing expense. In addition, gross margin as a percentage of net sales increased 20 basis points, reflecting

------

decreased shipping and warehouse expense and lower markdowns, partially offset by lower initial margins as a result of changes in brand mix. The decrease in selling and administrative expenses as a percentage of net sales demonstrates the impact of our cost savings initiatives and closing underperforming stores.

*Schuh Group*

---

| | | | |
|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** |  |
|  | **November 1, 2025** | November 2, 2024 | %<br>Change |
|  | (dollars in thousands) | (dollars in thousands) |  |
| Net sales | **$123766** | $121826 | 1.6% |
| Cost of sales | **72095** | 69477 |  |
| Gross margin | **51671** | 52349 | (1.3)% |
| &nbsp;&nbsp;&nbsp;&nbsp;% of sales | ***41.7%*** | *43.0%* |  |
| Selling and administrative expenses | **51002** | 49230 | 3.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;% of sales | ***41.2%*** | *40.4%* |  |
| Operating income | **$669** | $3119 | (78.6)% |
| Operating margin | **0.5%** | 2.6% |  |

---

Net sales from Schuh Group increased 1.6% to $123.8 million in the third quarter of Fiscal 2026 compared to $121.8 million in the third quarter of Fiscal 2025. The net sales increase for the third quarter of Fiscal 2026 includes a favorable impact of $3.7 million due to changes in foreign exchange rates and increased e-commerce comparable sales, partially offset by decreased same store sales. Schuh Group total comparable sales decreased 2% for the third quarter of Fiscal 2026. Schuh Group continued to contend with a challenging U.K. retail environment in the third quarter of Fiscal 2026. Schuh Group's e-commerce business remains a key channel for consumer engagement, accounting for over 40% of its sales in the third quarter of Fiscal 2026. Schuh Group's sales decreased 1% on a local currency basis for the third quarter of Fiscal 2026. Schuh Group operated 119 stores at the end of the third quarter of Fiscal 2026, compared to 122 stores at the end of the third quarter of Fiscal 2025.

The 210 basis point decrease in operating margin for Schuh Group for the third quarter of Fiscal 2026 compared to the third quarter of Fiscal 2025 was due to a 130 basis point decrease in gross margin as a percentage of net sales, reflecting increased promotional activity to match the competitive environment, partially offset by decreased shipping and warehouse expense. The decreased operating margin was also due to an 80 basis point increase in selling and administrative expenses as a percentage of net sales, reflecting deleverage of expenses in the third quarter of Fiscal 2026 on lower same store sales, especially selling salaries, professional fees and credit card expense, partially offset by decreased marketing expense.

*Johnston & Murphy Group*

---

| | | | |
|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** |  |
|  | **November 1, 2025** | November 2, 2024 | %<br>Change |
|  | (dollars in thousands) | (dollars in thousands) |  |
| Net sales | **$81157** | $78463 | 3.4% |
| Cost of sales | **38207** | 35895 |  |
| Gross margin | **42950** | 42568 | 0.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;% of sales | ***52.9%*** | *54.3%* |  |
| Selling and administrative expenses | **43545** | 42659 | 2.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;% of sales | ***53.7%*** | *54.4%* |  |
| Operating loss | **$(595)** | $(91) | NM |
| Operating margin | **(0.7)%** | (0.1)% |  |

---

Johnston & Murphy Group net sales increased 3.4% to $81.2 million for the third quarter of Fiscal 2026 from $78.5 million for the third quarter of Fiscal 2025, primarily due to increased wholesale sales, partially offset by a 2% decrease in comparable sales. The decline in comparable sales was primarily driven by softer e-commerce trends due to a shift in marketing spend. Retail operations accounted for 70.6% of Johnston & Murphy Group's sales in the third quarter of Fiscal 2026 versus 74.0% in the third quarter of Fiscal 2025. The store count for Johnston & Murphy Group's retail operations at the end of the third quarter of Fiscal 2026 and Fiscal 2025 was 152 full-price retail and factory stores. The store total at the end of the third quarter of Fiscal 2025 included five stores in Canada. Johnston & Murphy Group closed its five Canadian stores at the end of Fiscal 2025.

------

The 60 basis point decrease in operating margin for Johnston & Murphy Group for the third quarter of Fiscal 2026 compared to the third quarter of Fiscal 2025 reflects primarily a 140 basis point decrease in gross margin as a percentage of net sales due to a higher mix of wholesale sales as well as tariff impacts ahead of price increases in the wholesale channel, partially offset by improved initial margins in the retail channel as a result of price increases. The decrease in operating margin was partially offset by a 70 basis point decrease in selling and administrative expenses as a percentage of net sales for the third quarter of Fiscal 2026 compared to the third quarter of Fiscal 2025 primarily due to decreased marketing expense and selling salaries, partially offset by increased depreciation expense.

*Genesco Brands Group*

---

| | | | |
|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** |  |
|  | **November 1, 2025** | November 2, 2024 | %<br>Change |
|  | (dollars in thousands) | (dollars in thousands) |  |
| Net sales | **$34587** | $33522 | 3.2% |
| Cost of sales | **26851** | 21632 |  |
| Gross margin | **7736** | 11890 | (34.9)% |
| &nbsp;&nbsp;&nbsp;&nbsp;% of sales | ***22.4%*** | *35.5%* |  |
| Selling and administrative expenses | **7195** | 8161 | (11.8)% |
| &nbsp;&nbsp;&nbsp;&nbsp;% of sales | ***20.8%*** | *24.3%* |  |
| Operating income | **$541** | $3729 | (85.5)% |
| Operating margin | **1.6%** | 11.1% |  |

---

Genesco Brands Group's net sales increased 3.2% to $34.6 million for the third quarter of Fiscal 2026 from $33.5 million for the third quarter of Fiscal 2025 primarily due to increased footwear sales of Dockers and private label, partially offset by decreased footwear sales of other licenses.

The decrease in operating margin for Genesco Brands Group for the third quarter of Fiscal 2026 compared to the third quarter of Fiscal 2025 was primarily due to decreased gross margin as a percentage of net sales due to ongoing tariff pressure and higher closeout sales related to the exit of Levi's and other licenses. The decrease in operating margin was partially offset by decreased selling and administrative expenses as a percentage of net sales in the third quarter of Fiscal 2026 reflecting leverage of expenses as a result of increased revenue in the third quarter of Fiscal 2026, partially offset by increased professional fees and royalty expense.

*Corporate, Interest Expenses and Other Charges*

Corporate and other expense for the third quarter of Fiscal 2026 was $12.6 million compared to $9.7 million for the third quarter of Fiscal 2025. Corporate expense in the third quarter of Fiscal 2026 included asset impairment and other charges of $4.3 million for store restructuring, severance and asset impairments. Corporate expense in the third quarter of Fiscal 2025 included asset impairment and other charges of $0.1 million for asset impairments. The corporate expense decrease, excluding asset impairment and other charges, reflects decreased performance-based compensation expense in the third quarter of Fiscal 2026 compared to the third quarter of Fiscal 2025.

Net interest expense decreased 27.1% to $0.9 million in the third quarter of Fiscal 2026 compared to $1.2 million in the third quarter of Fiscal 2025 primarily reflecting decreased revolver borrowings in North America, partially offset by increased revolver borrowings in the U.K. in the third quarter of Fiscal 2026 compared to the third quarter of Fiscal 2025.

**Results of Operations – First Nine Months of Fiscal 2026 Compared to First Nine Months of Fiscal 2025**

Our net sales increased 3.6% to $1.64 billion in the first nine months of Fiscal 2026 compared to $1.58 billion in the first nine months of Fiscal 2025. The net sales increase compared to last year's first nine months reflects a 4% increase in comparable sales, including a 5% increase in same store sales reflecting investment in and a strategic focus on the store channel and a 1% increase in e-commerce comparable sales, a favorable foreign exchange impact and an increase in wholesale sales, partially offset by the impact of net store closings resulting from our store optimization efforts. The Journeys Group business was strong in the first nine months of Fiscal 2026 with comparable sales up 8%, fueled by strength in product assortment and other initiatives. Schuh Group comparable sales were down 2% for the first nine months of Fiscal 2026 reflecting the challenging retail environment in the U.K. Johnston & Murphy Group comparable sales were down 1% reflecting lower store sales in the first nine months of Fiscal 2026. By segment, Journeys Group sales increased 5%, Schuh Group sales increased 2% and Genesco Brands Group sales increased 5%, while Johnston & Murphy Group sales decreased 1% in the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025. Schuh Group's sales decreased 2% on a local currency basis for the first nine months of Fiscal 2026.

Gross margin increased 1.7% to $759.8 million in the first nine months of Fiscal 2026 from $747.2 million in the first nine months of Fiscal 2025, but decreased as a percentage of net sales from 47.3% in the first nine months of Fiscal 2025 to 46.4% in the first nine months of Fiscal 2026. The overall decrease in gross margin as a percentage of net sales is due primarily to increased promotional activity at Schuh Group and

------

lower margins at Genesco Brands Group related to the exit of Levi's and other licenses and the impact from tariffs, partially offset by decreased shipping and warehouse expense in Journeys Group and Schuh Group.

Selling and administrative expenses in the first nine months of Fiscal 2026 increased 1.4% to $789.0 million from $777.9 million compared to the first nine months of Fiscal 2025, but decreased 110 basis points as a percentage of net sales in the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025 from 49.3% to 48.2%. The decrease as a percentage of net sales reflects decreased occupancy expense and other cost savings initiatives.

Operating margin was (2.1)% in the first nine months of Fiscal 2026 compared to (2.0)% in the first nine months of Fiscal 2025. The overall decrease in operating margin for the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025 primarily reflects decreased gross margin as a percentage of net sales and higher asset impairment and other charges, partially offset by decreased expenses as a percentage of net sales.

The loss from continuing operations before income taxes ("pretax loss") for the first nine months of Fiscal 2026 was $38.2 million compared to a pretax loss of $35.9 million for the first nine months of Fiscal 2025. The pretax loss for the first nine months of Fiscal 2026 included asset impairment and other charges of $4.7 million for store restructuring, severance and asset impairments. The pretax loss for the first nine months of Fiscal 2025 included a $1.8 million charge for a distribution model transition in the Genesco Brands Group and asset impairment and other charges of $1.5 million for severance and asset impairments.

We had an effective income tax rate of 10.3% and (47.7)% in the first nine months of Fiscal 2026 and Fiscal 2025, respectively. The higher effective tax rate in the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025 reflects a $26.3 million U.S. valuation allowance recorded in the third quarter of Fiscal 2025 and the enactment of income tax law changes under the OBBBA in Fiscal 2026 and their interaction with our valuation allowance in the U.S. jurisdiction.

The net loss in the first nine months of Fiscal 2026 was $34.3 million, or $3.31 diluted loss per share, compared to a net loss of $53.3 million, or $4.90 diluted loss per share, in the first nine months of Fiscal 2025.

*Journeys Group*

---

| | | | |
|:---|:---|:---|:---|
|  | **Nine Months Ended** | **Nine Months Ended** |  |
|  | **November 1, 2025** | November 2, 2024 | %<br>Change |
|  | (dollars in thousands) | (dollars in thousands) |  |
| Net sales | **$967530** | $920808 | 5.1% |
| Cost of sales | **492712** | 469486 |  |
| Gross margin | **474818** | 451322 | 5.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;% of sales | ***49.1%*** | *49.0%* |  |
| Selling and administrative expenses | **474534** | 468129 | 1.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;% of sales | ***49.0%*** | *50.8%* |  |
| Operating income (loss) | **$284** | $(16807) | NM |
| Operating margin | ***0.0%*** | *(1.8)%* |  |

---

Net sales from Journeys Group increased 5.1% to $967.5 million in the first nine months of Fiscal 2026, compared to $920.8 million in the first nine months of Fiscal 2025. The net sales increase compared to the first nine months of Fiscal 2025 reflects an 8% increase in comparable sales, reflecting increased store sales, partially offset by a 5% decrease in the average number of stores in the first nine months of Fiscal 2026. The increased comparable sales in the first nine months of Fiscal 2026 was fueled by strength in Journeys Group's product assortment with brands across both casual and athletic posting strong gains and other initiatives. Journeys Group drove strong gains in conversion and transaction size for the first nine months this year.

The 180 basis point improvement in operating margin for Journeys Group for the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025 was due to decreased selling and administrative expenses as a percentage of net sales reflecting leverage of expense as a result of increased revenue in the first nine months of Fiscal 2026, especially occupancy expense and selling salaries. The improvement in operating margin was also due to an increase in gross margin as a percentage of net sales reflecting lower markdowns and decreased shipping and warehouse expense, partially offset by decreased initial margins as a result of changes in brand mix. The decrease in selling and administrative expenses as a percentage of net sales demonstrates the impact of our cost savings initiatives and closing underperforming stores.

------

*Schuh Group*

---

| | | | |
|:---|:---|:---|:---|
|  | **Nine Months Ended** | **Nine Months Ended** |  |
|  | **November 1, 2025** | November 2, 2024 | %<br>Change |
|  | (dollars in thousands) | (dollars in thousands) |  |
| Net sales | **$346276** | $338736 | 2.2% |
| Cost of sales | **207245** | 195777 |  |
| Gross margin | **139031** | 142959 | (2.7)% |
| &nbsp;&nbsp;&nbsp;&nbsp;% of sales | ***40.2%*** | *42.2%* |  |
| Selling and administrative expenses | **144504** | 138397 | 4.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;% of sales | ***41.7%*** | *40.9%* |  |
| Operating income (loss) | **$(5473)** | $4562 | NM |
| Operating margin | **(1.6)%** | 1.3% |  |

---

Net sales from Schuh Group increased 2.2% to $346.3 million in the first nine months of Fiscal 2026 compared to $338.7 million in the first nine months of Fiscal 2025. Net sales for the first nine months of Fiscal 2026 includes a favorable impact of $12.8 million due to changes in foreign exchange rates and an increase in e-commerce comparable sales, partially offset by decreased same store sales. Schuh Group performance was impacted by the ongoing challenging U.K. retail environment in the first nine months of Fiscal 2026. Schuh Group's e-commerce business remains a key channel for consumer engagement, accounting for over 40% of its sales in the first nine months of Fiscal 2026. Schuh Group total comparable sales decreased 2% for the first nine months of Fiscal 2026. Schuh Group's sales decreased 2% on a local currency basis for the first nine months of Fiscal 2026.

Operating margin decreased 290 basis points for Schuh Group for the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025 due to decreased gross margin as a percentage of net sales, reflecting increased promotional activity, including increased loyalty redemptions and promotions to match the competitive environment, and changes in brand mix, partially offset by decreased shipping and warehouse expenses. In addition, selling and administrative expenses increased as a percentage of net sales, reflecting deleverage of expenses, especially occupancy expense and selling salaries, partially offset by decreased compensation expense.

*Johnston & Murphy Group*

---

| | | | |
|:---|:---|:---|:---|
|  | **Nine Months Ended** | **Nine Months Ended** |  |
|  | **November 1, 2025** | November 2, 2024 | %<br>Change |
|  | (dollars in thousands) | (dollars in thousands) |  |
| Net sales | **$226785** | $228707 | (0.8)% |
| Cost of sales | **105540** | 106277 |  |
| Gross margin | **121245** | 122430 | (1.0)% |
| &nbsp;&nbsp;&nbsp;&nbsp;% of sales | ***53.5%*** | *53.5%* |  |
| Selling and administrative expenses | **123122** | 120569 | 2.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;% of sales | ***54.3%*** | *52.7%* |  |
| Operating income (loss) | **$(1877)** | $1861 | NM |
| Operating margin | **(0.8)%** | 0.8% |  |

---

Johnston & Murphy Group net sales decreased 0.8% to $226.8 million for the first nine months of Fiscal 2026 from $228.7 million for the first nine months of Fiscal 2025, primarily due to decreased same store sales and a 3% decrease in the average number of stores in the first nine months of Fiscal 2026, partially offset by increased wholesale sales. Total comparable sales for Johnston & Murphy Group were down 1% for the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025. Retail operations accounted for 74.9% of Johnston & Murphy Group's sales in the first nine months of Fiscal 2026 versus 76.0% in the first nine months of Fiscal 2025.

The 160 basis point decrease in operating margin for Johnston & Murphy Group for the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025 reflects increased selling and administrative expenses as a percentage of net sales for the first nine months of Fiscal 2026 primarily due to the deleverage of expenses, especially depreciation expense as a result of decreased revenue in the first nine months of Fiscal 2026. Gross margin as a percentage of net sales for the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025 was flat, as better retail margins were offset by lower wholesale margins due to tariff impacts ahead of price increases in the wholesale channel, a higher mix of wholesale sales and an increase in shipping and warehouse expense.

------

*Genesco Brands Group*

---

| | | | |
|:---|:---|:---|:---|
|  | **Nine Months Ended** | **Nine Months Ended** |  |
|  | **November 1, 2025** | November 2, 2024 | %<br>Change |
|  | (dollars in thousands) | (dollars in thousands) |  |
| Net sales | **$95564** | $90862 | 5.2% |
| Cost of sales | **70900** | 60397 |  |
| Gross margin | **24664** | 30465 | (19.0)% |
| &nbsp;&nbsp;&nbsp;&nbsp;% of sales | ***25.8%*** | *33.5%* |  |
| Selling and administrative expenses | **22772** | 25050 | (9.1)% |
| &nbsp;&nbsp;&nbsp;&nbsp;% of sales | ***23.8%*** | *27.6%* |  |
| Operating income | **$1892** | $5415 | (65.1)% |
| Operating margin | **2.0%** | 6.0% |  |

---

Genesco Brands Group's net sales increased 5.2% to $95.6 million for the first nine months of Fiscal 2026 from $90.9 million for the first nine months of Fiscal 2025 primarily due to increased sales of Levi's and private label footwear.

The decrease in operating margin for Genesco Brands Group for the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025 was primarily due to decreased gross margin as a percentage of net sales due to higher closeout sales related to the exit of Levi's and other licenses and the impact of tariffs as well as an unfavorable change in sales mix, partially offset by a $1.8 million inventory provision for a distribution model transition in the first nine months of Fiscal 2025. The decrease in operating margin was partially offset by decreased selling and administrative expenses as a percentage of net sales in the first nine months of Fiscal 2026 reflecting leverage of expenses as a result of increased revenue in the first nine months of Fiscal 2026 and decreased performance-based compensation expense.

*Corporate, Interest Expenses and Other Charges*

Corporate and other expense for the first nine months of Fiscal 2026 was $28.8 million compared to $27.2 million for the first nine months of Fiscal 2025. Corporate expense in the first nine months of Fiscal 2026 included asset impairment and other charges of $4.7 million for store restructuring, severance and asset impairments. Corporate expense in the first nine months of Fiscal 2025 included asset impairment and other charges of $1.5 million for severance and asset impairments. The corporate expense decrease, excluding asset impairment and other charges, reflects decreased performance-based compensation expense and professional fees in the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025, partially offset by increased compensation.

Net interest expense increased 6.8% to $3.7 million in the first nine months of Fiscal 2026 compared to $3.4 million in the first nine months of Fiscal 2025 primarily reflecting increased revolver borrowings in the U.K. and lower interest income, partially offset by decreased revolver borrowings in North America in the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025.

------

**Liquidity and Capital Resources**

*Working Capital* 

Our business is seasonal, with our investment in working capital normally reaching peaks in the summer and fall of each year in anticipation of the back-to-school and holiday selling seasons. Historically, cash flows from operations typically have been generated principally in the fourth quarter of each fiscal year.

---

| | | | |
|:---|:---|:---|:---|
|  | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| Cash flow changes: | November 1, 2025 | November 2, 2024 | Increase<br>(Decrease) |
| (in thousands) |  |  |  |
| Net cash used in operating activities | **$(27597)** | $(29108) | $1511 |
| Net cash used in investing activities | **(52185)** | (27396) | (24789) |
| Net cash provided by financing activities | **72435** | 54543 | 17892 |
| Effect of foreign exchange rate fluctuations on cash | **374** | 384 | (10) |
| Net decrease in cash and cash equivalents | **$(6973)** | $(1577) | $(5396) |

---

Reasons for the major variances in cash provided by (used in) the table above are as follows:

Cash used in operating activities was $1.5 million lower in the first nine months of Fiscal 2026 compared to the first nine months of Fiscal 2025, reflecting primarily the following factors:

• a $63.8 million increase in cash flow from changes in prepaids and other current assets, primarily reflecting the receipt of a $58.3 million income tax refund receivable; partially offset by

• a $52.9 million decrease in cash flow from changes in accounts payable, primarily reflecting changes in buying patterns in the first nine months of Fiscal 2026.

Cash used in investing activities was $24.8 million higher for the first nine months of Fiscal 2026 as compared to the first nine months of Fiscal 2025 reflecting increased capital expenditures primarily related to investments in retail stores.

Cash provided by financing activities was $17.9 million higher in the first nine months of Fiscal 2026 as compared to the first nine months of Fiscal 2025 primarily reflecting increased net borrowings.

*Sources of Liquidity and Future Capital Needs*

We have three principal sources of liquidity: cash flow from operations, cash on hand and our credit facilities discussed in Item 8, Note 8, "Long-Term Debt", to our Consolidated Financial Statements included in our Annual Report on Form 10-K for Fiscal 2025.

As of November 1, 2025, we have borrowed $65.0 million U.S. revolver borrowings, $4.8 million (CAD $6.7 million) revolver borrowings related to GCO Canada ULC and $19.7 million (£15.0 million) related to Schuh revolver borrowings. The Facility Agreement in the U.K. was extended through February 28, 2026. We were in compliance with all the relevant terms and conditions of the Credit Facility and the Facility Agreement as of November 1, 2025.

We believe that cash on hand, cash provided by operations and borrowings under our Credit Facility and the Facility Agreement will be sufficient to support our liquidity needs in Fiscal 2026 and the foreseeable future.

On January 17, 2025, we executed Form 870 with the Internal Revenue Service ("IRS") exam team and began the process of completing the separate Joint Committee on Taxation ("JCT") review of our outstanding U.S. Federal tax refund claim for the Fiscal 2014 to Fiscal 2021 tax periods. As of February 1, 2025, we estimated the refund outstanding to be $59.3 million including interest. During the first quarter of Fiscal 2026, the JCT finalized their review with no changes to the claim and the IRS began the process of issuing the refund. The balance outstanding increased to $60.2 million as a result of additional accrued interest. We received $58.3 million of the refund during the second quarter of Fiscal 2026. The remaining $1.9 million outstanding represents additional interest not yet paid by the IRS as of November 1, 2025. As such, the $1.9 million receivable is classified as prepaids and other current assets on the Condensed Consolidated Balance Sheets as of November 1, 2025. We received $1.5 million of the remaining interest due from the IRS in November 2025 and expect to receive the majority of the remaining $0.4 million interest in the fourth quarter of Fiscal 2026.

------

*Contractual Obligations* 

Our contractual obligations at November 1, 2025 increased 26% compared to February 1, 2025, primarily due to increased long-term debt and lease obligations.

*Capital Expenditures*

Total capital expenditures in Fiscal 2026 are expected to be approximately $55 to $65 million of which approximately 80% is for new stores and renovations and 20% is for other initiatives. We do not currently have any longer-term capital expenditures or other cash requirements other than as set forth above and in the contractual obligations table as disclosed in Item 7 of our Annual Report on Form 10-K for the fiscal year ended February 1, 2025. We also do not currently have any off-balance sheet arrangements.

*Common Stock Repurchases* 

We did not repurchase any shares of our common stock during the third quarter of Fiscal 2026. We repurchased 604,531 shares of our common stock during the first nine months of Fiscal 2026 at a cost of $12.6 million, or an average cost of $20.79 per share. We have $29.8 million remaining as of November 1, 2025 under our expanded share repurchase authorization announced in June 2023. We repurchased 17,922 shares of our common stock during the third quarter of Fiscal 2025 at a cost of $0.4 million, or an average cost of $24.50 per share, and repurchased 399,633 shares of common stock during the first nine months of Fiscal 2025 at a cost of $9.8 million, or an average cost of $24.49 per share. During the fourth quarter of Fiscal 2026, through December 11, 2025, we have not repurchased any shares of our common stock.

**Environmental and Other Contingencies**

We are subject to certain loss contingencies related to environmental proceedings and other legal matters, including those disclosed in Item 1, Note 7, "Legal Proceedings", to our Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q.

**New Accounting Pronouncements**

Descriptions of recently issued accounting pronouncements, if any, and the accounting pronouncements adopted by us during the third quarter of Fiscal 2026 are included in Note 1 to our Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q.

**Item 3. Quantitative and Qualitative Disclosures about Market Risk**

We incorporate by reference the information regarding market risk appearing in Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations" under the heading "Financial Market Risk" in our Annual Report on Form 10-K for the fiscal year ended February 1, 2025. There have been no material changes to our exposure to market risks from those disclosed in the Annual Report on Form 10-K for the fiscal year ended February 1, 2025.

**Item 4. Controls and Procedures**

*Evaluation of Disclosure Controls and Procedures*

We have established disclosure controls and procedures designed to ensure that information required to be disclosed by us, including our consolidated subsidiaries, in the reports we file or submit under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is made known to the officers who certify our financial reports and to other members of senior management. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving desired objectives.

Based on their evaluation as of November 1, 2025, the principal executive officer and principal financial officer of the Company have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Exchange Act) were effective to ensure that the information required to be disclosed by us in the reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within time periods specified in SEC rules and forms and (ii) accumulated and communicated to our management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure.

*Changes in Internal Control Over Financial Reporting*

There were no changes in our internal control over financial reporting that occurred during our third quarter of Fiscal 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

**PART II - OTHER INFORMATION**

**Item 1. Legal Proceedings**

We incorporate by reference the information regarding legal proceedings in Item 1, Note 7, "Legal Proceedings", to our Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q.

**Item 1A. Risk Factors** 

Reference is made to the factors set forth under the caption "Cautionary Notice Regarding Forward-Looking Statements" in this quarterly report on Form 10-Q and other risk factors described in our Annual Report on Form 10-K for the fiscal year ended February 1, 2025, which are incorporated herein by reference. There have not been any material changes to the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended February 1, 2025, except as set forth below.

You should carefully consider these risk factors, all or any of which could materially affect our business, financial condition or future results. The risks described in this report and in our Annual Report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

**Government actions and regulations, including tariffs, export restrictions and other trade protection measures, may have a material adverse impact on our business.** 

The Company's business is subject to risks related to tariffs and other trade policies put in place by the U.S. and/or other countries since most of the goods we sell are imported from outside the U.S. The goods sold through our retail businesses (approximately 80% of our sales) are sourced by our vendor partners and we directly source the goods sold by our branded businesses (approximately 20% of our sales). Over the past several years, we have worked to diversify our direct sourcing with a focus on reducing exposure to countries where tariffs are high and we have previously identified tariff and trade policy as a risk factor. In 2025, the U.S. government announced the imposition of additional tariffs on certain goods imported from numerous countries, including China, Brazil, India and Vietnam. Multiple nations, including China, responded with reciprocal tariffs and other trade actions. The recent enactment of tariffs by the U.S. government, along with the unpredictability of the rates and other potential actions that may be taken by the U.S. government and foreign governments (including trade restrictions, new or increased tariffs or quotas, embargoes, sanctions and counter sanctions, safeguards or customs restrictions) may materially increase our costs and reduce our margins. These actions may also lead to higher pricing for our products, potentially reducing consumer demand and impacting our sales. We are actively monitoring the impact of any tariffs that become effective, as well as potential retaliatory actions by other countries. We are currently taking actions to mitigate this cost pressure, including accelerating, increasing or canceling inventory, further diversifying suppliers and re-sourcing to countries with lower tariffs, working with longstanding factory partners to reduce costs, identifying further cost reductions across our business and planning for strategic price increases. However, there can be no assurance that we will be able to implement any strategies in a timely fashion, that these measures will be successful, or that they will offset the negative impact of the tariffs and other government actions on our business.

Given the uncertainty regarding scope and duration of the current and potential tariffs, as well as the potential for additional trade actions by the U.S. or other countries, the specific impact to our business, results of operations, cash flows and financial condition is uncertain but could be material.

------

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds** 

<u>Repurchases</u> (shown in thousands except share and per share amounts):

---

| | | | | |
|:---|:---|:---|:---|:---|
| **ISSUER PURCHASES OF EQUITY SECURITIES** | **ISSUER PURCHASES OF EQUITY SECURITIES** | **ISSUER PURCHASES OF EQUITY SECURITIES** | **ISSUER PURCHASES OF EQUITY SECURITIES** | **ISSUER PURCHASES OF EQUITY SECURITIES** |
| Period | (a) Total<br>Number of<br>Shares<br>Purchased | (b) Average<br>Price<br>Paid<br>per Share | (c) Total<br>Number of<br>Shares<br>Purchased <br>as Part<br>of Publicly<br>Announced<br>Plans or<br>Programs | (d) Maximum<br>Number<br>(or Approximate<br>Dollar Value)<br>of Shares that<br>May Yet Be<br>Purchased<br>Under the<br>Plans or<br>Programs |
| August 2025 |  |  |  |  |
| 8-3-25 to 8-30-25<sup>(1)</sup> |  | $— |  | $29755 |
| 8-3-25 to 8-30-25<sup>(2)</sup> | 342 | $24.49 |  |  |
| September 2025 |  |  |  |  |
| 8-31-25 to 9-27-25<sup>(1)</sup> |  | $— |  | $29755 |
| October 2025 |  |  |  |  |
| 9-28-25 to 11-1-25 <sup>(1)</sup> |  | $— |  | $29755 |
| 9-28-25 to 11-1-25 <sup>(2)</sup> | 1296 | $29.83 |  |  |
| Total | 1638 | $28.71 |  | $29755 |
| <sup>(1)</sup> Share repurchases were made pursuant to a $100.0 million share repurchase program approved by our Board of Directors and announced in February 2022, and in June 2023, our Board of Directors approved an additional $50.0 million for share repurchases. We expect to implement the balance of the repurchase program through purchases made from time to time either in the open market or through private transactions, in accordance with the regulations of the SEC and other applicable legal requirements. The timing and amount of any shares repurchased under the program will depend on a variety of factors, including price, corporate and regulatory requirements, capital availability, and other market conditions. The repurchase program may be limited, temporarily paused, or terminated by our Board of Directors at any time without prior notice. | <sup>(1)</sup> Share repurchases were made pursuant to a $100.0 million share repurchase program approved by our Board of Directors and announced in February 2022, and in June 2023, our Board of Directors approved an additional $50.0 million for share repurchases. We expect to implement the balance of the repurchase program through purchases made from time to time either in the open market or through private transactions, in accordance with the regulations of the SEC and other applicable legal requirements. The timing and amount of any shares repurchased under the program will depend on a variety of factors, including price, corporate and regulatory requirements, capital availability, and other market conditions. The repurchase program may be limited, temporarily paused, or terminated by our Board of Directors at any time without prior notice. | <sup>(1)</sup> Share repurchases were made pursuant to a $100.0 million share repurchase program approved by our Board of Directors and announced in February 2022, and in June 2023, our Board of Directors approved an additional $50.0 million for share repurchases. We expect to implement the balance of the repurchase program through purchases made from time to time either in the open market or through private transactions, in accordance with the regulations of the SEC and other applicable legal requirements. The timing and amount of any shares repurchased under the program will depend on a variety of factors, including price, corporate and regulatory requirements, capital availability, and other market conditions. The repurchase program may be limited, temporarily paused, or terminated by our Board of Directors at any time without prior notice. | <sup>(1)</sup> Share repurchases were made pursuant to a $100.0 million share repurchase program approved by our Board of Directors and announced in February 2022, and in June 2023, our Board of Directors approved an additional $50.0 million for share repurchases. We expect to implement the balance of the repurchase program through purchases made from time to time either in the open market or through private transactions, in accordance with the regulations of the SEC and other applicable legal requirements. The timing and amount of any shares repurchased under the program will depend on a variety of factors, including price, corporate and regulatory requirements, capital availability, and other market conditions. The repurchase program may be limited, temporarily paused, or terminated by our Board of Directors at any time without prior notice. | <sup>(1)</sup> Share repurchases were made pursuant to a $100.0 million share repurchase program approved by our Board of Directors and announced in February 2022, and in June 2023, our Board of Directors approved an additional $50.0 million for share repurchases. We expect to implement the balance of the repurchase program through purchases made from time to time either in the open market or through private transactions, in accordance with the regulations of the SEC and other applicable legal requirements. The timing and amount of any shares repurchased under the program will depend on a variety of factors, including price, corporate and regulatory requirements, capital availability, and other market conditions. The repurchase program may be limited, temporarily paused, or terminated by our Board of Directors at any time without prior notice. |
| <sup>(2)</sup> These shares represent shares withheld from vested restricted stock to satisfy the minimum withholding requirement for federal and state taxes. | <sup>(2)</sup> These shares represent shares withheld from vested restricted stock to satisfy the minimum withholding requirement for federal and state taxes. | <sup>(2)</sup> These shares represent shares withheld from vested restricted stock to satisfy the minimum withholding requirement for federal and state taxes. | <sup>(2)</sup> These shares represent shares withheld from vested restricted stock to satisfy the minimum withholding requirement for federal and state taxes. | <sup>(2)</sup> These shares represent shares withheld from vested restricted stock to satisfy the minimum withholding requirement for federal and state taxes. |

---

**Item 5. Other Information**

**<u>Insider Trading Arrangements</u>**

During the third quarter of Fiscal 2026, no director or officer (as defined in Section 16 of the Exchange Act) of the Company adopted or terminated any "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement" (in each case, as defined in Item 408 (a) and (c) of Regulation S-K).

------

**Item 6. Exhibits**

---

| | |
|:---|:---|
| **Exhibit Index** |  |
| 31.1 | [<u>Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</u>](gco-ex31_1.htm) |
| 31.2 | [<u>Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</u>](gco-ex31_2.htm) |
| 32.1 | [<u>Certification of the Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</u>](gco-ex32_1.htm) |
| 32.2 | [<u>Certification of the Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</u>](gco-ex32_2.htm) |
| 101 | The following materials from Genesco Inc.'s Quarterly Report on Form 10-Q for the quarter ended November 1, 2025, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets at November 1, 2025, February 1, 2025 and November 2, 2024, (ii) Condensed Consolidated Statements of Operations for each of the three and nine months ended November 1, 2025 and November 2, 2024, (iii) Condensed Consolidated Statements of Comprehensive Income (Loss) for each of the three and nine months ended November 1, 2025 and November 2, 2024, (iv) Condensed Consolidated Statements of Cash Flows for the nine months ended November 1, 2025 and November 2, 2024, (v) Condensed Consolidated Statements of Equity for each of the three and nine months ended November 1, 2025 and November 2, 2024, and (vi) Notes to the Condensed Consolidated Financial Statements. |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |

---

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
| Genesco Inc. | Genesco Inc. |
| By: | /s/ Cassandra E. Harris |
|  | Cassandra E. Harris |
|  | Senior Vice President - Finance and <br>Chief Financial Officer |

---

Date: December 11, 2025

------

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATIONS**

I, Mimi E. Vaughn, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Genesco Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: December 11, 2025

---

| |
|:---|
| /s/ Mimi E. Vaughn |
| Mimi E. Vaughn |
| Chief Executive Officer |

---

------

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATIONS**

I, Cassandra E. Harris, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Genesco Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: December 11, 2025

---

| |
|:---|
| /s/ Cassandra E. Harris |
| Cassandra E. Harris |
| Senior Vice President - Finance and Chief Financial Officer |

---

------

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Genesco Inc. (the "Company") on Form 10-Q for the period ending November 1, 2025, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Mimi E. Vaughn, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| /s/ Mimi E. Vaughn |
| Mimi E. Vaughn |
| Chief Executive Officer |
| December 11, 2025 |

---

------

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Genesco Inc. (the "Company") on Form 10-Q for the period ending November 1, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Cassandra E. Harris, Senior Vice President - Finance and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| /s/ Cassandra E. Harris |
| Cassandra E. Harris |
| Senior Vice President - Finance and Chief Financial Officer |
| December 11, 2025 |

---

------